Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI
Deepak L. Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI Advisory Board
Anne Valente MD
Anne Marie Valente MD Advisory Board
Peter Libby MD
Peter Libby MD Advisory Board
See All Experts
story of the week
Published in Cardiology and
1 other channel

Journal Scan / Research · May 04, 2016

Dipeptidyl Peptidase-4 Inhibitors and Hospitalized Heart Failure

Annals of Internal Medicine

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Benjamin Scirica MD

Annals of Internal Medicine
Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort Study
Ann. Intern. Med 2016 Apr 26;[EPub Ahead of Print], S Toh, C Hampp, ME Reichman, DJ Graham, S Balakrishnan, F Pucino, J Hamilton, S Lendle, A Iyer, M Rucker, M Pimentel, N Nathwani, MR Griffin, NJ Brown, BH Fireman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated